Menu

Blog

Page 2436

Aug 11, 2023

Cruise and Waymo win robotaxi expansions in San Francisco

Posted by in categories: robotics/AI, transportation

In a win for the autonomous vehicle industry, California regulators have given the green light to Cruise and Waymo to offer commercial robotaxi services across San Francisco 24 hours a day, seven days a week.

The commission voted 3–1 in support of the expansions; Commissioner Genevieve Shiroma cast the sole “no” vote.

The California Public Utilities Commission’s (CPUC) votes in favor of the AV companies come in spite of mounting opposition from residents and city agencies that have urged caution and a more incremental approach to expansion. Since AVs hit the streets of San Francisco, there have been numerous instances of vehicles malfunctioning and stopping in the middle of the street — referred to as “bricking” — blocking the flow of traffic, public transit and emergency responders.

Aug 11, 2023

National Aviation Hall of Fame Honors ForeFlight Co-Founder Tyson Weihs

Posted by in categories: innovation, transportation

The Board of Trustees of the National Aviation Hall of Fame, or NAHF, named Tyson Weihs, co-founder and former CEO of ForeFlight, winner of its 2023 Armstrong Award.

The award recognizes Weihs for his “innovative spirit, commitment to safety, and service to the aviation community,” the NAHF said. Many pilots are using ForeFlight every day who would agree that the platform represents a game-changer in general aviation.

Aug 11, 2023

I Have No Mouth, and I Must Scream — FULL Audiobook (Harlan Ellison Version)

Posted by in category: futurism

Science fiction hell.

Aug 11, 2023

IT HAPPENED: NVIDIA Finally Reveals Its 4 Next Gen AI UPGRADES (GH200 + 600 Extensions + 3.5X MORE)

Posted by in category: robotics/AI

Introducing Nvidia’s most recently announced major advancements in the Omniverse platform to collaborations with giants like Adobe and Wonder Dynamics. Also, Dive into the revolutionary GH200 Grace Hopper AI Superchip platform, boasting unparalleled memory technology and a collaboration with Hugging-Face. Finally, explore the collaboration between Nvidia and Shutterstock, unveiling tools that redefine 3D scene development, all powered by Nvidia’s Picasso and generative AI.

Deep Learning AI Specialization: https://imp.i384100.net/GET-STARTED
AI Marketplace: https://taimine.com/

Continue reading “IT HAPPENED: NVIDIA Finally Reveals Its 4 Next Gen AI UPGRADES (GH200 + 600 Extensions + 3.5X MORE)” »

Aug 11, 2023

New physics or not? I’ll sort it out for you

Posted by in categories: cosmology, particle physics, quantum physics

All this and stamp collecting?paraphrase Lord Kelvin.


If you’d like to learn more about quantum mechanics, use our link https://brilliant.org/sabine — You can get started for free, and the first 200 will get 20% off the annual premium subscription.

Continue reading “New physics or not? I’ll sort it out for you” »

Aug 11, 2023

High Dimensional Quantum Machine Learning With Small Quantum Computers

Posted by in categories: quantum physics, robotics/AI

Simon C. Marshall, Casper Gyurik, and Vedran Dunjko.

Leiden University, Leiden, The Netherlands.

Get full text pdfRead on arXiv VanityComment on Fermat’s library.

Aug 11, 2023

Japanese Scientists Construct Complex 3D Organoids With Ingenious Device

Posted by in categories: biotech/medical, genetics

A team of scientists led by Masaya Hagiwara of RIKEN national science institute in Japan has developed an ingenious device, using layers of hydrogels in a cube-like structure, that allows researchers to construct complex 3D organoids without using elaborate techniques. The group also recently demonstrated the ability to use the device to build organoids that faithfully reproduce the asymmetric genetic expression that characterizes the actual development of organisms. The device has the potential to revolutionize the way we test drugs, and could also provide insights into how tissues develop and lead to better techniques for growing artificial organs.

Scientists have long struggled to create organoids—organ-like tissues grown in the laboratory—to replicate actual biological development. Creating organoids that function similarly to real tissues is vital for developing medicines since it is necessary to understand how drugs move through various tissues. Organoids also help us gain insights into the process of development itself and are a stepping stone on the way to growing whole organs that can help patients.

Aug 11, 2023

Tesla Cybertruck spotted next to Rivian R1T for size comparison

Posted by in category: transportation

With only a few Tesla Cybertruck prototypes out there, it has rarely been spotted next to another electric pickup truck for a nice size comparison.

But now we get to see it next to a Rivian R1T.

We are likely weeks away from the first Cybertruck deliveries, yet we don’t have the finalized specs and dimensions of the electric pickup truck.

Aug 11, 2023

A Drug For Regrowing Teeth Could Be Available Within The Next Decade

Posted by in category: biotech/medical

Teeth don’t grow back once we become adults: any wear and tear is permanent – as those of us with fillings will know – which is why it’s important to keep them as clean and healthy as we can.

However, this is something scientists are now looking to change.

It’s been announced that clinical trials for a potential tooth regrowth treatment are set to begin in July 2024, building on decades of research in the field. If those trials are successful, therapeutic drugs could be available by 2030.

Aug 11, 2023

MaxCyte signs strategic platform license with prime medicine to advance next-generation gene editing therapies for patients

Posted by in categories: bioengineering, biotech/medical, genetics

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the signing of a strategic partnership with Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies.